Biovaccine Stocks Rally, CanSino Surges Over 11%
On August 27, biovaccine concept stocks traded actively, with CanSino Biologics leading gains of over 11%. Other notable risers included Zhifei Biologics, Zhongyuan, Olymvax, BCHT, and Saili Medical, reflecting a broad sector uptick.
On August 27, biovaccine concept stocks showed active trading in the market, with multiple shares posting gains. CanSino Biologics rose more than 11%, making it one of the leading gainers in the sector. Meanwhile, Zhifei Biologics, Zhongyuan, Olymvax, BCHT, and Saili Medical also advanced in tandem. The upward movement of these stocks reflected the overall trend in the biovaccine sector that day.